| Literature DB >> 34493330 |
David M Poché1, Kelsey Dawson2, Batchimeg Tseveenjav2, Richard M Poché2.
Abstract
BACKGROUND: Lyme disease, caused primarily by Borrelia burgdorferi sensu stricto, is the most prevalent vector-borne disease in the United States. Treatment of rodent pathogen reservoirs with an oral acaricide may suppress the production of infected host-seeking ticks posing a risk for human infection. A previous study showed that an oral fipronil bait effectively controlled larval Ixodes scapularis ticks on white-footed mice (Peromyscus leucopus) up to 15 days post-bait exposure. The present study expands upon this finding by exposing group-housed white-footed mice to fipronil bait under simulated field conditions prior to tick infestation.Entities:
Keywords: Acaricides; Blacklegged ticks; Borrelia burgdorferi sensu stricto; Fipronil bait; Ixodes scapularis; Peromyscus leucopus; Simulated field conditions; Systemic insecticides; Vector control; White-footed mice
Mesh:
Substances:
Year: 2021 PMID: 34493330 PMCID: PMC8424918 DOI: 10.1186/s13071-021-04930-z
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Fig. 1Conceptual diagram for the experimental design of the study. a Mice group-housed in a large enclosure and presented with bait station, alternative diet, water source, and shelter. b Control group mice received no fipronil bait prior to being transferred to the insectary for tick exposure. Larvae were allowed to feed to repletion and molt. c Treatment group mice were presented with bait stations loaded with fipronil bait. d Mice transferred to the insectary for tick exposure. Fipronil bait prevents larvae from feeding to repletion and molting
Summary of the mouse enclosures utilized during acclimation, exposure, and post-exposure
| Enclosure ID | Sex | Test group ID | Treatment/control | Bait exposure duration | No. mice |
|---|---|---|---|---|---|
| 1 | Male | T24 | Treatment | 24 h (reduced) | 10 |
| 2 | Female | T24 | Treatment | 24 h (reduced) | 10 |
| 3 | Male | C24 | Control | 24 h (reduced) | 10 |
| 4 | Female | C24 | Control | 24 h (reduced) | 10 |
| 5 | Male | T168 | Treatment | 168 h (extended) | 10 |
| 6 | Female | T168 | Treatment | 168 h (extended) | 10 |
| 7 | Male | C168 | Control | 168 h (extended) | 10 |
| 8 | Female | C168 | Control | 168 h (extended) | 10 |
Fig. 2Overhead view of an enclosure housing 10 treatment group mice. The bait station and alternative diet are positioned equidistance from the water source and shelter
Study specifics for each group and subgroup of white-footed mice utilized
| Bait exposure duration | Test group ID | Subgroup ID | Day of tick application (post-bait exposure) | No. mice | No. larvae/mouse |
|---|---|---|---|---|---|
| Reduced | T24 | T24-1 | Day 1 | 10 | 40 |
| T24-15 | Day 15 | 10 | 40 | ||
| C24 | C24-1 | Day 1 | 10 | 40 | |
| C24-15 | Day 15 | 10 | 40 | ||
| Extended | T168 | T168-21 | Day 21 | 10 | 40 |
| T168-35 | Day 35 | 10 | 40 | ||
| C168 | C168-21 | Day 21 | 10 | 40 | |
| C168-35 | Day 35 | 10 | 40 |
Fig. 3Replete blacklegged tick larvae collected from moats being dried on a sheet of filter paper
Fig. 4Comparison of a engorging larvae feeding on control mouse, and b non-engorged, deceased larvae on treatment mouse. Engorging larvae are bloated and excreting red feces (green arrows). Non-engorged, deceased larvae are brown and desiccated (red arrows)
Fig. 5a Test tube containing replete larvae and molted nymphs, b closer view of a test tube with several molted nymphs
Initial and final body weight (g) for white-footed mice within each test group (mean ± SD)
| Test group | Bait exposure | Sex | Body weight (g) | |
|---|---|---|---|---|
| Initial | Final | |||
| Treatment | Reduced | Male | 22.3 ± 2.0 | 22.7 ± 1.8 |
| Female | 21.9 ± 3.1 | 21.8 ± 2.4 | ||
| Total | 22.1 ± 2.6 | 22.3 ± 2.1 | ||
| Extended | Male | 21.2 ± 1.9 | 21.5 ± 2.0 | |
| Female | 20.9 ± 1.9 | 19.9 ± 2.5 | ||
| Total | 21.2 ± 1.9 | 20.7 ± 2.3 | ||
| Control | Reduced | Male | 23.0 ± 2.6 | 22.5 ± 1.9 |
| Female | 20.6 ± 2.0 | 20.4 ± 2.0 | ||
| Total | 21.8 ± 2.2 | 21.5 ± 2.2 | ||
| Extended | Male | 21.8 ± 1.9 | 22.4 ± 3.1 | |
| Female | 21.3 ± 4.6 | 20.4 ± 2.7 | ||
| Total | 21.6 ± 3.5 | 21.4 ± 3.0 | ||
Comparison of consumption of fipronil bait and challenge diet (CD) within the treatment and control groups of white-footed mice
| Treatment | Control | ||||||
|---|---|---|---|---|---|---|---|
| Test group | Sex | Diet | Consumption (g) | Test group | Sex | Diet | Consumption (g) |
| Reduced bait exposure | Male ( | Fipronil bait | 38.0 | Reduced bait exposure | Male ( | CD | 42.0 |
| CD | 4.3 | ||||||
| Female ( | Fipronil bait | 31.6 | Female ( | CD | 42.7 | ||
| CD | 6.5 | ||||||
| Extended bait exposure | Male ( | Fipronil Bait | 138.4 | Extended bait exposure | Male ( | CD | 273.2 |
| CD | 122.0 | ||||||
| Female ( | Fipronil bait | 136.3 | Female ( | CD | 170.8 | ||
| CD | 48.0 | ||||||
Estimated individual fipronil consumption by treatment group white-footed mice (n = 40)
| Treatment group | Sex | Mean body weight ± SD (g) | Mean total bait consumed/mouse (g) | Mean bait consumed/mouse/day (g) | Mean daily fipronil consumed/mouse (mg) | Mean daily fipronil consumed/mouse (mg/kg) |
|---|---|---|---|---|---|---|
| Reduced bait exposure | Male | 22.3 ± 2.0 | 3.8 | 3.8 | 0.19 | 8.5 |
| Female | 21.9 ± 3.1 | 3.2 | 3.2 | 0.16 | 7.3 | |
| Extended bait exposure | Male | 21.2 ± 1.9 | 13.8 | 2.0 | 0.10 | 4.7 |
| Female | 20.9 ± 1.9 | 13.6 | 1.9 | 0.10 | 4.8 |
Summary of non-engorged and replete blacklegged tick larvae collected from moats per day post-tick attachment
| Mouse test group | Larvae | Number of larvae collected from moats (days post-tick attachment) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Day 1 | Day 2 | Day 3 | Day 4 | Total | |||||||
| Non-engorged | Replete | Non-engorged | Replete | Non-engorged | Replete | Non-engorged | Replete | Non-engorged | Replete | ||
| C24-1 | 400 | 53 | 0 | 2 | 0 | 2 | 40 | 1 | 120 | 58 | 160 |
| T24-1 | 400 | 51 | 0 | 10 | 0 | 10 | 0 | 5 | 0 | 76 | 0 |
| C24-15 | 400 | 61 | 0 | 12 | 0 | 4 | 13 | 1 | 105 | 78 | 118 |
| T24-15 | 400 | 82 | 0 | 17 | 0 | 13 | 2 | 6 | 11 | 118 | 13 |
| C168-21 | 400 | 91 | 0 | 9 | 0 | 7 | 12 | 0 | 129 | 107 | 141 |
| T168-21 | 400 | 80 | 0 | 26 | 0 | 15 | 1 | 6 | 19 | 127 | 20 |
| C168-35 | 400 | 116 | 0 | 11 | 0 | 1 | 3 | 0 | 106 | 128 | 109 |
| T168-35 | 360 | 112 | 0 | 20 | 0 | 11 | 5 | 0 | 19 | 143 | 24 |
| Control total | 1600 | 321 | 0 | 34 | 0 | 14 | 68 | 2 | 460 | 371 | 528 |
| Treatment total | 1560 | 325 | 0 | 73 | 0 | 49 | 8 | 17 | 49 | 464 | 57 |
Summary of the total number and mean non-engorged and replete blacklegged tick larvae collected from moats over the course of post-tick attachment
| Mouse test group | Total larvae introduced onto mice | Larvae collected from moats | |||||
|---|---|---|---|---|---|---|---|
| Total non-engorged larvae recovered | Mean ± SD non-engorged larvae per mouse | Proportion of mice with non-engorged larvae (%) | Total replete larvae recovered | Mean ± SD replete larvae per mouse | Proportion of mice with replete larvae (%) | ||
| C24-1 | 400 | 58 | 5.8 ± 4.5 | 100 | 160 | 16.0 ± 4.9 | 100 |
| T24-1 | 400 | 76 | 7.6 ± 4.6 | 100 | 0 | 0 | 0 |
| C24-15 | 400 | 78 | 7.8 ± 2.9 | 100 | 118 | 11.8 ± 3.9 | 100 |
| T24-15 | 400 | 118 | 11.8 ± 5.6 | 100 | 13 | 1.3 ± 4.1 | 10 |
| C168-21 | 400 | 107 | 10.7 ± 4.2 | 100 | 141 | 14.1 ± 2.8 | 100 |
| T168-21 | 400 | 127 | 12.7 ± 6.7 | 100 | 20 | 2.0 ± 3.3 | 40 |
| C168-35 | 400 | 128 | 12.8 ± 5.8 | 100 | 109 | 10.9 ± 2.6 | 100 |
| T168-35 | 360 | 143 | 15.9 ± 7.0 | 100 | 24 | 2.7 ± 1.7 | 88.9 |
| Control total | 1600 | 371 | 9.3 ± 5.1 | 100 | 528 | 13.2 ± 4.1 | 100 |
| Treatment total | 1560 | 464 | 11.9 ± 6.5 | 100 | 57 | 1.5 ± 2.9 | 33.3 |
Mean number of attached blacklegged tick larvae (±SD) per mouse observable within each capsule within each test group
| Test group | Observable attached ticks, post-tick attachment | |||||||
|---|---|---|---|---|---|---|---|---|
| Day 2 | Day 4 | |||||||
| Non-engorged | Engorging | Non-engorged | Engorging | |||||
| Total | Mean ± SD | Total | Mean ± SD | Total | Mean ± SD | Total | Mean ± SD | |
| C24-1 | 16 | 1.6 ± 2.0 | 107 | 10.7 ± 2.5 | 1 | 0.1 ± 0.3 | 14 | 1.4 ± 1.6 |
| T24-1 | 125 | 12.5 ± 2.1 | 0 | 0 | 132 | 13.2 ± 2.3 | 0 | 0 |
| C24-15 | 33 | 3.3 ± 1.3 | 82 | 8.2 ± 2.7 | 3 | 0.3 ± 0.5 | 21 | 2.1 ± 1.0 |
| T24-15 | 136 | 13.6 ± 2.5 | 7 | 0.7 ± 1.3 | 147 | 14.7 ± 2.9 | 4 | 0.4 ± 1.0 |
| C168-21 | 25 | 2.5 ± 1.8 | 95 | 9.5 ± 4.0 | 6 | 0.6 ± 1.0 | 26 | 2.6 ± 2.0 |
| T168-21 | 107 | 10.7 ± 2.4 | 16 | 1.6 ± 2.3 | 114 | 11.4 ± 2.3 | 4 | 0.4 ± 0.7 |
| C168-35 | 30 | 3.0 ± 2.4 | 79 | 7.9 ± 2.0 | 9 | 0.9 ± 1.1 | 32 | 3.2 ± 1.6 |
| T168-35 | 55 | 6.1 ± 2.7 | 37 | 4.1 ± 1.4 | 70 | 7.8 ± 2.6 | 17 | 1.9 ± 1.4 |
| Control total | 104 | 2.6 ± 2.0 | 363 | 9.1 ± 3.0 | 19 | 0.5 ± 0.8 | 93 | 2.3 ± 1.7 |
| Treatment total | 423 | 10.8 ± 3.7 | 60 | 1.5 ± 2.1 | 463 | 11.9 ± 3.5 | 25 | 0.6 ± 1.1 |
Summary of replete blacklegged tick larvae successfully molting for each test group
| Test group ID | Total mice | Mean larvae placed in each capsule day 0 | Total replete larvae placed in desiccator | Mean replete larvae placed in desiccator | Total replete larvae molting | Mean replete larvae molting |
|---|---|---|---|---|---|---|
| C24-15 | 10 | 40 | 118 | 11.8 | 79 | 7.9 |
| T24-15 | 10 | 40 | 13 | 1.3 | 7 | 0.7 |
| C168-21 | 10 | 40 | 141 | 14.1 | 96 | 9.6 |
| T168-21 | 10 | 40 | 20 | 2 | 8 | 0.8 |
| C168-35 | 10 | 40 | 109 | 10.9 | 80 | 8 |
| T168-35 | 9 | 40 | 24 | 2.7 | 13 | 1.4 |
Fipronil sulfone concentrations in white-footed mice utilized in tick attachments
| Sex | Group ID | Group | Exposure | Attachment time point (post-exposure) | Blood collection time point (post-exposure) | Fipronil sulfone (ng/ml) | Number of replete ticks successfully detaching |
|---|---|---|---|---|---|---|---|
| Male | T24-1 | Treatment | 24 h | Day 1 | Day 5 | 96.3 | 0 |
| Male | T24-1 | Treatment | 24 h | Day 1 | Day 5 | 140.3 | 0 |
| Male | T24-1 | Treatment | 24 h | Day 1 | Day 5 | 222.7 | 0 |
| Male | T24-1 | Treatment | 24 h | Day 1 | Day 5 | 247.4 | 0 |
| Male | T24-1 | Treatment | 24 h | Day 1 | Day 5 | 361.9 | 0 |
| Female | T24-1 | Treatment | 24 h | Day 1 | Day 5 | 161.5 | 0 |
| Female | T24-1 | Treatment | 24 h | Day 1 | Day 5 | 234.7 | 0 |
| Female | T24-1 | Treatment | 24 h | Day 1 | Day 5 | 75.6 | 0 |
| Female | T24-1 | Treatment | 24 h | Day 1 | Day 5 | 134.4 | 0 |
| Female | T24-1 | Treatment | 24 h | Day 1 | Day 5 | 239.7 | 0 |
| Male | T24-15 | Treatment | 24 h | Day 15 | Day 19 | 78.8 | 0 |
| Male | T24-15 | Treatment | 24 h | Day 15 | Day 19 | 15.5 | 0 |
| Male | T24-15 | Treatment | 24 h | Day 15 | Day 19 | ND | 13 |
| Male | T24-15 | Treatment | 24 h | Day 15 | Day 19 | 12.7 | 0 |
| Male | T24-15 | Treatment | 24 h | Day 15 | Day 19 | 40.3 | 0 |
| Female | T24-15 | Treatment | 24 h | Day 15 | Day 19 | 18.8 | 0 |
| Female | T24-15 | Treatment | 24 h | Day 15 | Day 19 | 16.2 | 0 |
| Female | T24-15 | Treatment | 24 h | Day 15 | Day 19 | 4.4 | 0 |
| Female | T24-15 | Treatment | 24 h | Day 15 | Day 19 | 79.3 | 0 |
| Female | T24-15 | Treatment | 24 h | Day 15 | Day 19 | 28.2 | 0 |
| Male | T168-21 | Treatment | 168 h | Day 21 | Day 25 | 32 | 0 |
| Male | T168-21 | Treatment | 168 h | Day 21 | Day 25 | 11.9 | 0 |
| Male | T168-21 | Treatment | 168 h | Day 21 | Day 25 | 25.7 | 0 |
| Male | T168-21 | Treatment | 168 h | Day 21 | Day 25 | 19.4 | 0 |
| Male | T168-21 | Treatment | 168 h | Day 21 | Day 25 | ND | 8 |
| Female | T168-21 | Treatment | 168 h | Day 21 | Day 25 | ND | 0 |
| Female | T168-21 | Treatment | 168 h | Day 21 | Day 25 | 4.8 | 1 |
| Female | T168-21 | Treatment | 168 h | Day 21 | Day 25 | ND | 9 |
| Female | T168-21 | Treatment | 168 h | Day 21 | Day 25 | ND | 2 |
| Female | T168-21 | Treatment | 168 h | Day 21 | Day 25 | 11.8 | 0 |
| Male | T168-35 | Treatment | 168 h | Day 35 | Day 39 | ND | 2 |
| Male | T168-35 | Treatment | 168 h | Day 35 | Day 39 | 8.8 | 0 |
| Male | T168-35 | Treatment | 168 h | Day 35 | Day 39 | ND | 1 |
| Male | T168-35 | Treatment | 168 h | Day 35 | Day 39 | ND | 5 |
| Male | T168-35 | Treatment | 168 h | Day 35 | Day 39 | ND | 2 |
| Female | T168-35 | Treatment | 168 h | Day 35 | Day 39 | ND | 5 |
| Female | T168-35 | Treatment | 168 h | Day 35 | Day 39 | ND | 2 |
| Female | T168-35 | Treatment | 168 h | Day 35 | Day 39 | ND | 4 |
| Female | T168-35 | Treatment | 168 h | Day 35 | Day 39 | ND | 3 |
| Male | C24-1 | Control | NA | Day 1 | Day 5 | ND | 19 |
| Female | C24-1 | Control | NA | Day 1 | Day 5 | ND | 10 |
| Male | C168-35 | Control | NA | Day 35 | Day 39 | ND | 11 |
| Female | C168-35 | Control | NA | Day 35 | Day 39 | ND | 7 |
ND = No fipronil sulfone detected at levels > 1.25 ng/ml (LOQ)